中东和非洲肺癌筛查软件市场，按交付方式（基于云的解决方案、本地解决方案和基于 Web 的解决方案）、产品（肺癌筛查放射学解决方案、肺癌筛查患者管理软件、结节管理软件、数据收集和报告、患者协调和工作流程、肺结节计算机辅助检测、病理学和癌症分期、统计审计报告、筛查 PAC、实践管理和审计日志跟踪）、类型（计算机辅助筛查和传统筛查）、应用（非小细胞肺癌 (NSCLC)和小细胞肺癌 (SCLC)）、平台（独立和集成）、购买模式（机构和个人）、最终用户（肿瘤中心、医院、门诊手术中心等）、分销渠道（直接招标和第三方分销商） - 行业趋势和预测到 2029 年。
中东和非洲肺癌筛查软件市场分析和规模
控制肺癌死亡率是医疗机构的主要关注点之一。公共和私人组织正在积极推出筛查计划，以控制死亡率。此外，公司正在推出先进的软件，以简化患者数据的管理，并在严格的数据隐私准则下提供更好的护理。
肺癌患病率上升、人们对肺癌的认识不断提高、政府举措不断增加以及筛查项目数量不断增加是推动市场增长的一些主要因素。此外，人工智能 (AI) 解决方案的进步和主要市场参与者的战略举措正在为肺癌筛查软件领域创造机会。
然而，预计数据隐私问题和非熟练劳动力的缺乏将在预测期内阻碍市场增长。
Data Bridge Market Research 分析称，中东和非洲肺癌筛查软件市场预计到 2029 年将达到 83.545 万美元的价值，预测期内的复合年增长率为 14.9%。基于云的解决方案占市场交付模式的最大份额。市场报告还深入介绍了定价分析、专利分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020 (可定制为 2019-2014) |
|
定量单位 |
收入（千美元），定价（美元） |
|
涵盖的领域 |
按交付方式（基于云的解决方案、本地解决方案和基于 Web 的解决方案）、产品（肺癌筛查放射学解决方案、肺癌筛查患者管理软件、结节管理软件、数据收集和报告、患者协调和工作流程、肺结节计算机辅助检测、病理学和癌症分期、统计审计报告、筛查 PAC、实践管理和审计日志跟踪）、类型（计算机辅助筛查和传统筛查）、应用（非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC)）、平台（独立和集成）、购买模式（机构和个人）、最终用户（肿瘤中心、医院、门诊手术中心等）、分销渠道（直接招标和第三方分销商） |
|
覆盖国家 |
阿联酋、沙特阿拉伯、以色列、埃及、南非以及中东和非洲其他地区 |
|
涵盖的市场参与者 |
PenRad Technologies Inc.、Koninklijke Philips NV、Volpara Health Limited、Thynk Health、Nuance Communications, Inc.、Siemens Healthcare GmbH、MyCareWare, Inc.、MagView、MeVis Medical Solutions AG、Canon Medical Informatics, Inc.、通用电气公司、Epic Systems Corporation、Lungview、Eon、Medtronic、Coreline Soft Co., Ltd.、Optellum Ltd、HealthMyne、Oncocyte Corporation、Genesystem、REVEALDX、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche Ltd、Median Technologies、AstraZeneca 和 Aidence.com |
市场定义
肺癌筛查是使用不同的技术和软件识别肺癌的分期。使用 CT 进行肺癌筛查是筛查肺癌最推荐的技术。该技术的使用日益广泛，预计将加速对肺癌筛查先进软件的需求。该软件有助于管理患者参与肺癌筛查计划，并为医疗保健专业人员提供一种有效的方式来收集、整理和传输数据给临床医生和患者。此外，该软件能够识别处于危险中的患者，并通过集成的电子健康记录实现数据流自动化。
中东和非洲肺癌筛查软件市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
驱动程序
- 全球肺癌发病率上升
肺癌是男性和女性死亡的主要原因。根据世界癌症研究基金会国际部的数据，肺癌是全球第二大常见癌症。它是男性中最常见的癌症，也是女性中第二常见的癌症。2020 年新增肺癌病例超过 2.2 万例。肺癌病例的不断增加使得需要采用肺癌筛查软件进行早期诊断，并成为市场增长的驱动因素。
- 提高对早期诊断和频繁筛查益处的认识
公共、非营利和私人组织不断增加的肺癌宣传计划预计将推动市场增长。这些举措旨在预防疾病、减少耻辱和偏见并促进研究。民众对肺癌的认识有所提高。由于不同组织开展了许多宣传计划，人们知道如果及早诊断，肺癌是可以治愈的。因此，提高民众的认识正在推动市场增长。
- 政府采取措施，实施各类疾病的筛查计划
癌症负担在全球范围内持续增加，给卫生系统、产品、家庭和个人带来巨大的经济、情感和身体压力。在卫生系统强大的国家，由于存活率、优质护理、意识增强和早期检测方便，许多类型癌症的存活率得到改善。美国疾病控制和预防中心、部落以及美国太平洋岛屿和地区通过国家综合癌症控制计划 (NCCCP) 组建或支持联盟，以对抗其社区中的癌症。由于这些举措，更多的受众受到了教育，并且更加自觉地传播，推动全球受众采取进一步的预防措施并进行预防性检查，从而促进市场发展。
- 全球筛查项目数量不断增加
筛查是检测早期癌症的有效方法。发展中国家的肺癌发病率呈上升趋势。虽然有定期筛查乳腺癌和宫颈癌的建议，但肺癌的情况却并非如此。大多数国家或机构已启动低剂量计算机断层扫描 (LDCT) 对肺癌的可行性和疾病筛查。肺癌筛查数量的增加为市场参与者创造了机会。因此，诊断率的提高是市场增长的驱动因素。
机会
-
市场参与者之间的合作、并购不断增加
在市场上运营的公司正在采取多种策略，包括并购、产品发布、协议、渠道开发、合作和市场扩张等，以在各个方面促进其业务。这些公司的战略决策预计将为在市场上运营的市场参与者提供重大机遇。
限制/挑战
- 与软件可用性相关的问题
在发展中国家，有效和高效的肺癌筛查以及肺癌筛查软件的可用性存在一些问题/障碍。问题包括时间竞争需求、肺癌筛查知识、对筛查有效性的态度变化、与历史上不良的肺癌治疗结果相关的虚无主义以及地方当局或国家医疗器械监管机构的培训和要求批准有限。所有这些问题都推迟了产品的发布和可用性。此外，由于与可用软件相关的技术问题，对肺癌筛查软件的需求受到阻碍，从而限制了市场增长。
新冠肺炎疫情对中东和非洲肺癌筛查软件市场的影响
COVID-19 对各行各业产生了重大影响，因为几乎每个国家都选择关闭除经营必需品部门的设施以外的所有设施。政府采取了一些严格的措施，例如关闭设施和销售非必需品、阻止国际贸易等，以防止 COVID-19 的传播。在这种大流行情况下，唯一仍在运营的业务是获准开放和运行流程的基本服务。
COVID-19 为医疗服务提供者提供患者护理带来了新的、不熟悉的挑战。许多非必要但重要的服务（如肺癌筛查）被暂时暂停，以保护员工和患者的健康。医疗机构在安排、患者监测和跟进患者服务沟通方面面临着前所未有的挑战，以确保在 COVID-19 期间护理的连续性以及何时可以安全地继续提供服务。COVID-19 为肺癌筛查计划带来了新的挑战，在许多情况下，筛查被推迟了几个月，给管理和安排团队带来了更多困难。尽管 COVID-19 危机让人们再次认识到呼吸辅助的重要性，但希望它能对减少癌症筛查的耻辱感产生重大影响。美国有超过 10,000,000 名符合肺癌筛查条件的患者，其中只有不到 5% 的人积极参加了筛查计划。COVID-19 对市场产生了负面影响。
然而，肺癌筛查软件公司正在苦苦挣扎，并不断采取不同的战略决策来控制局面。参与者参与战略活动，如伙伴关系、协作、并购等，以改进市场涉及的技术。通过这种方式，公司将为市场带来先进和准确的解决方案。此外，政府推动跨行业数字化的举措也推动了市场增长。
最新动态
- 2022 年 7 月，GE Healthcare 推出了其最新产品和最先进的超声波，即下一代 Voluson Expert 22。GE Healthcare 屡获殊荣的女性健康产品组合的这一最新产品采用基于图形的波束形成器技术，可生成更高质量的图像并在成像功能方面提供更大的灵活性。凭借这款产品，该公司在医疗机构的产品和服务提供商领域的地位得到了进一步加强。
- 2021 年 10 月，Thynk Health 宣布与 Infervision 建立合作伙伴关系，利用世界上最先进的技术对抗肺癌。它为肺癌筛查和肺结节管理提供了机会。通过此次合作，该公司提高了其市场占有率。
中东和非洲肺癌筛查软件市场范围
中东和非洲肺癌筛查软件市场根据交付方式、产品、类型、应用、平台、购买模式、最终用户和分销渠道分为八个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
交付方式
- 基于云的解决方案
- 本地解决方案
- 基于 Web 的解决方案
根据交付方式，市场分为基于云的解决方案、内部部署解决方案和基于网络的解决方案。
产品
- 肺癌筛查放射学解决方案
- 肺癌筛查患者管理软件
- 结节管理软件
- 数据收集和报告
- 患者协调和工作流程
- 肺结节计算机辅助检测
- 病理学和癌症分期
- 统计审计报告
- 筛查 PACS
- 实践管理
- 审计日志追踪
根据产品，市场细分为肺癌筛查放射学解决方案、肺癌筛查患者管理软件、结节管理软件、数据收集和报告、患者协调和工作流程、肺结节计算机辅助检测、病理和癌症分期、统计审计报告、筛查 PACS、实践管理和审计日志跟踪。
类型
- 计算机辅助筛查
- 传统筛查
根据类型，市场分为计算机辅助筛选和传统筛选。
应用
根据应用，市场分为非小细胞肺癌（NSCLC）和小细胞肺癌（SCLC）。
平台
- 独立
- 融合的
根据平台不同，市场分为独立平台和集成平台。
购买方式
- 机构
- 个人
根据购买模式，市场分为个人市场和机构市场。
最终用户
- 肿瘤中心
- 医院
- 门诊手术中心
- 其他的
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others.
Distribution Channel
- Direct Tender
- Third Party Distributors
On the basis of distribution channel, the market is segmented into direct tender and third party distributors.
Middle East and Africa Lung Cancer Screening Software Market Regional Analysis/Insights
Middle East and Africa market is analyzed and market size insights and trends are provided based on mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel as referenced above.
The countries covered in this market report are U.A.E., Saudi Arabia, Israel, Egypt, South Africa, and rest of Middle East and Africa. Saudi Arabia dominates the market owing to factors such as, on-going strategic partnerships and the presence of major key players in the region. Moreover, some underdeveloped countries in this region do not have access to technological services in the healthcare sector which has led to the region slow growth in the market.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Lung Cancer Screening Software Market Share Analysis
Middle East and Africa lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, and Aidence.com among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS & REIMBURSEMENT
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES MIDDLE EAST & AFRICALY
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
6.2 RESTRAINTS
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE
6.4 CHALLENGES
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE
6.4.3 INCREASING COMPETITION IN THE MARKET
7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY
7.1 OVERVIEW
7.2 CLOUD BASED SOLUTIONS
7.3 ON-PREMISE SOLUTIONS
7.4 WEB BASED SOLUTIONS
8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION
8.2.1 ON-PREMISE SOLUTIONS
8.2.2 WEB BASED SOLUTIONS
8.2.3 CLOUD BASED SOLUTIONS
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE
8.3.1 CLOUD BASED SOLUTIONS
8.3.2 ON-PREMISE SOLUTIONS
8.3.3 WEB BASED SOLUTIONS
8.4 NODULE MANAGEMENT SOFTWARE
8.4.1 CLOUD BASED SOLUTIONS
8.4.2 ON-PREMISE SOLUTIONS
8.4.3 WEB BASED SOLUTIONS
8.5 DATA COLLECTION AND REPORTING
8.5.1 CLOUD BASED SOLUTIONS
8.5.2 WEB BASED SOLUTIONS
8.5.3 ON-PREMISE SOLUTIONS
8.6 PATIENT COORDINATION AND WORKFLOW
8.6.1 CLOUD BASED SOLUTIONS
8.6.2 ON-PREMISE SOLUTIONS
8.6.3 WEB BASED SOLUTIONS
8.7 LUNG NODULE COMPUTER AIDED DETECTION
8.7.1 ON-PREMISE SOLUTIONS
8.7.2 CLOUD BASED SOLUTIONS
8.7.3 WEB BASED SOLUTIONS
8.8 PATHOLOGY AND CANCER STAGING
8.8.1 CLOUD BASED SOLUTIONS
8.8.2 ON-PREMISE SOLUTIONS
8.8.3 WEB BASED SOLUTIONS
8.9 STATISTICAL AUDIT REPORTING
8.9.1 CLOUD BASED SOLUTIONS
8.9.2 ON-PREMISE SOLUTIONS
8.9.3 WEB BASED SOLUTIONS
8.1 SCREENING PACS
8.10.1 CLOUD BASED SOLUTIONS
8.10.2 ON-PREMISE SOLUTIONS
8.10.3 WEB BASED SOLUTIONS
8.11 PRACTICE MANAGEMENT
8.11.1 CLOUD BASED SOLUTIONS
8.11.2 ON-PREMISE SOLUTIONS
8.11.3 WEB BASED SOLUTIONS
8.12 AUDIT LOG TRACKING
8.12.1 CLOUD BASED SOLUTIONS
8.12.2 ON-PREMISE SOLUTIONS
8.12.3 WEB BASED SOLUTIONS
9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE
9.1 OVERVIEW
9.2 COMPUTER-ASSISTED SCREENING
9.2.1 CLOUD BASED SOLUTIONS
9.2.2 ON-PREMISE SOLUTIONS
9.2.3 WEB BASED SOLUTIONS
9.3 TRADITIONAL SCREENING
9.3.1 CLOUD BASED SOLUTIONS
9.3.2 ON-PREMISE SOLUTIONS
9.3.3 WEB BASED SOLUTIONS
10 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 NON-SMALL CELL LUNG CANCER (NSCLC)
10.2.1 CLOUD BASED SOLUTIONS
10.2.2 ON-PREMISE SOLUTIONS
10.2.3 WEB BASED SOLUTIONS
10.3 SMALL CELL LUNG CANCER (SCLC)
10.3.1 CLOUD BASED SOLUTIONS
10.3.2 ON-PREMISE SOLUTIONS
10.3.3 WEB BASED SOLUTIONS
11 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM
11.1 OVERVIEW
11.2 STANDALONE
11.2.1 CLOUD BASED SOLUTIONS
11.2.2 ON-PREMISE SOLUTIONS
11.2.3 WEB BASED SOLUTIONS
11.3 INTEGRATED
11.3.1 CLOUD BASED SOLUTIONS
11.3.2 ON-PREMISE SOLUTIONS
11.3.3 WEB BASED SOLUTIONS
12 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 INSTITUTIONAL
12.3 INDIVIDUAL
13 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER
13.1 OVERVIEW
13.2 ONCOLOGY CENTERS
13.3 HOSPITALS
13.4 AMBULATORY SURGICAL CENTERS
13.5 OTHERS
14 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDERS
14.3 THIRD PARTY DISTRIBUTOR
15 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION
15.1 MIDDLE EAST & AFRICA
15.1.1 SOUTH AFRICA
15.1.2 SOUTH AFRICA
15.1.3 U.A.E
15.1.4 ISRAEL
15.1.5 EGYPT
15.1.6 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 KONINKLIJKE PHILIPS N.V
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 SIEMENS HEALTHCARE GMBH
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 NUANCE COMMUNICATIONS, INC.
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 GENRAL ELECTRIC (GE HEALTHCARE)
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ONCOCYTE CORPORATION
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 AIDENCE.COM
18.6.1 COMPANY SNAPSHOT
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 ASTRAZENECA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANON MEDICAL INFORMATICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 CORELINE SOFT, CO., LTD.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 EON
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 EPIC SYSTEMS CORPORATION
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 F. HOFFMANN-LA ROCHE LTD
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 GENESYSTEM
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 HEALTHMYNE
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 LUNGVIEW
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MAGVIEW
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 MEDIAN TECHNOLOGIES
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 MEDTRONIC
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 MEVIS MEDICAL SOLUTIONS AG
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENT
18.21 MYCAREWARE INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 OPTELLUM LTD
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 PENRAD TECHNOLOGIES INC.
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 REVEALDX
18.24.1 COMPANY SNAPSHOT
18.24.2 PRODUCT PORTFOLIO
18.24.3 RECENT DEVELOPMENT
18.25 THYNK HEALTH
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
18.26 VOLPARA SOLUTIONS LIMITED
18.26.1 COMPANY SNAPSHOT
18.26.2 REVENUE ANALYSIS
18.26.3 PRODUCT PORTFOLIO
18.26.4 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 2 MIDDLE EAST & AFRICA CLOUD BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 3 MIDDLE EAST & AFRICA ON-PREMISE SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 4 MIDDLE EAST & AFRICA WEB BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 5 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 6 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 11 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 12 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 13 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 14 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 15 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 16 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 17 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 18 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 19 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 20 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 21 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 22 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 23 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 24 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 25 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 26 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 27 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 28 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 29 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 30 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 31 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 32 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 33 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 34 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 35 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 36 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 37 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 38 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 39 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 40 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 41 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 42 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 43 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 44 MIDDLE EAST & AFRICA INSTITUTIONAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 45 MIDDLE EAST & AFRICA INDIVIDUAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 46 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 47 MIDDLE EAST & AFRICA ONCOLOGY CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 48 MIDDLE EAST & AFRICA HOSPITALS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 49 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 50 MIDDLE EAST & AFRICA OTHERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 51 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 53 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTOR IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 54 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 55 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 56 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 57 MIDDLE EAST & AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 58 MIDDLE EAST & AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 59 MIDDLE EAST & AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 60 MIDDLE EAST & AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 61 MIDDLE EAST & AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 62 MIDDLE EAST & AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 63 MIDDLE EAST & AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 64 MIDDLE EAST & AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 65 MIDDLE EAST & AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 66 MIDDLE EAST & AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 67 MIDDLE EAST & AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 68 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 69 MIDDLE EAST & AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 70 MIDDLE EAST & AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 71 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 72 MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 73 MIDDLE EAST & AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 74 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 75 MIDDLE EAST & AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 76 MIDDLE EAST & AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 77 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 78 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 79 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 80 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 81 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 82 SAUDI ARABIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 83 SAUDI ARABIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 84 SAUDI ARABIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 85 SAUDI ARABIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 86 SAUDI ARABIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 87 SAUDI ARABIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 88 SAUDI ARABIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 89 SAUDI ARABIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 90 SAUDI ARABIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 91 SAUDI ARABIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 92 SAUDI ARABIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 93 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 94 SAUDI ARABIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 95 SAUDI ARABIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 96 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 97 SAUDI ARABIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 98 SAUDI ARABIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 99 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 100 SAUDI ARABIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 101 SAUDI ARABIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 102 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 103 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 104 SAUDI ARABIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 105 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 106 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 107 SOUTH AFRICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 108 SOUTH AFRICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 109 SOUTH AFRICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 110 SOUTH AFRICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 111 SOUTH AFRICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 112 SOUTH AFRICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 113 SOUTH AFRICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 114 SOUTH AFRICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 115 SOUTH AFRICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 116 SOUTH AFRICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 117 SOUTH AFRICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 118 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 119 SOUTH AFRICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 120 SOUTH AFRICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 121 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 122 SOUTH AFRICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 123 SOUTH AFRICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 124 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 125 SOUTH AFRICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 126 SOUTH AFRICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 127 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 128 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 129 SOUTH AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 130 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 131 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 132 U.A.E LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 133 U.A.E LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 134 U.A.E NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 135 U.A.E DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 136 U.A.E PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 137 U.A.E LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 138 U.A.E PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 139 U.A.E STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 140 U.A.E SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 141 U.A.E PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 142 U.A.E AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 143 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 144 U.A.E COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 145 U.A.E TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 146 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 147 U.A.E NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 148 U.A.E SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 149 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 150 U.A.E STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 151 U.A.E INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 152 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 153 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 154 U.A.E LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 155 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 156 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 157 ISRAEL LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 158 ISRAEL LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 159 ISRAEL NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 160 ISRAEL DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 161 ISRAEL PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 162 ISRAEL LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 163 ISRAEL PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 164 ISRAEL STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 165 ISRAEL SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 166 ISRAEL PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 167 ISRAEL AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 168 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 169 ISRAEL COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 170 ISRAEL TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 171 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 172 ISRAEL NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 173 ISRAEL SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 174 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 175 ISRAEL STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 176 ISRAEL INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 177 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 178 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 179 ISRAEL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 180 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 181 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 182 EGYPT LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 183 EGYPT LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 184 EGYPT NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 185 EGYPT DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 186 EGYPT PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 187 EGYPT LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 188 EGYPT PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 189 EGYPT STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 190 EGYPT SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 191 EGYPT PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 192 EGYPT AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 193 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 194 EGYPT COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 195 EGYPT TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 196 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 197 EGYPT NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
TABLE 198 EGYPT SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 199 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 200 EGYPT STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 201 EGYPT INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 202 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 203 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 204 EGYPT LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 205 REST OF MIDDLE EAST AND AFRICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING LUNG CANCER SCREENING PROGRAMS IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 CLOUD BASED SOLUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET
FIGURE 14 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, 2021
FIGURE 15 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, 2021
FIGURE 16 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: TYPE, 2021
FIGURE 17 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, 2021
FIGURE 18 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, 2021
FIGURE 19 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, 2021
FIGURE 20 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, 2021
FIGURE 21 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 22 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2021)
FIGURE 23 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2021)
FIGURE 24 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2022 & 2029)
FIGURE 25 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2021 & 2029)
FIGURE 26 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY (2022-2029)
FIGURE 27 MIDDLE EAST & AFRICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
